PRKN and Parkinson disease: These valinomycin-induced parkin puncta did not appear in iPSC-derived dopaminergic neurons from a PD patient with compound heterozygous PRKN mutations (deletion of exon 2 and duplication of exon 6)17 (Supplementary Fig. 4), confirming the specificity of the signal.